Pericardiocentesis nursing: subxiphoid needle angle, Beck's triad, and monitoring

Pericardiocentesis is the needle aspiration of fluid from the pericardial sac – the fibrous membrane surrounding the heart. Nurses do not perform the procedure, but they are responsible for recognizing when it is needed, preparing the patient, monitoring during the procedure, and managing post-procedure care. For the NCLEX, cardiac tamponade and pericardiocentesis are consistently tested because they require fast recognition and precise clinical priorities.

Quick reference: cardiac tamponade vs stable pericardial effusion

What is cardiac tamponade?

Cardiac tamponade occurs when fluid in the pericardial sac accumulates fast enough – or in large enough volume – to compress the cardiac chambers and impair filling. The pericardium is relatively non-distensible: a slow accumulation of 1,000 mL may be tolerated, but a rapid 150 mL can be fatal.

As intrapericardial pressure rises, it exceeds the diastolic filling pressure of the right ventricle first (the lowest-pressure chamber). The RV collapses during diastole, reducing stroke volume. The left side follows. Cardiac output falls, blood pressure drops, and compensatory tachycardia develops. Without drainage, circulatory collapse and cardiac arrest follow.

Beck’s triad

Beck’s triad is the classic examination finding in cardiac tamponade. All three elements reflect the same pathophysiology – fluid compressing the heart from the outside:

1. Hypotension – reduced stroke volume and cardiac output
2. Jugular venous distension (JVD) – elevated venous pressure as blood backs up behind the compressed right heart
3. Muffled (distant) heart sounds – fluid surrounding the heart dampens sound transmission

Beck’s triad is taught as a diagnostic set, and the 2025 ESC guidelines are explicit that it often fails to appear in full. Beck originally described the triad in “surgical” tamponade – acute intrapericardial hemorrhage from trauma, myocardial rupture, or aortic rupture – where fluid accumulates in minutes. In “medical” tamponade, where fluid accumulates slowly, the triad may be lacking altogether: hypotension is only mildly reduced in subacute and chronic tamponade, and JVD can be absent in a hypovolemic patient. Recognize the pattern and act on partial findings.

Pulsus paradoxus

Pulsus paradoxus is a drop in systolic blood pressure of more than 10 mmHg during normal inspiration. In tamponade, inspiration increases venous return to the right heart; the distended RV shifts the interventricular septum leftward, reducing left ventricular filling and stroke volume.

How to measure: inflate a sphygmomanometer cuff 20 mmHg above systolic pressure. Slowly deflate. Note the pressure at which Korotkoff sounds first appear (on expiration only). Continue deflating until sounds are present on both inspiration and expiration. The difference between these two readings is pulsus paradoxus. Greater than 10 mmHg is abnormal; greater than 20 mmHg in the context of known pericardial disease strongly suggests tamponade.

ECG findings in cardiac tamponade

See cardiac arrhythmias nursing and 12-lead ECG interpretation for more on rhythm recognition.

Kussmaul’s sign

Kussmaul’s sign is a paradoxical rise in JVD during inspiration – the opposite of what normally happens. It reflects impaired right heart filling against a fixed, non-compliant boundary.

Its diagnostic value lies in its absence in tamponade. Kussmaul’s sign is characteristic of constrictive pericarditis, and it also appears in right ventricular infarction, restrictive cardiomyopathy, and severe right heart failure. It is a recognized discriminator between constriction and tamponade precisely because tamponade does not produce it – in tamponade the jugular venous pressure falls or stays flat on inspiration. The jugular waveform separates them the same way: tamponade shows a prominent x descent with an absent y descent, while constriction shows prominent x and y descents. Worth knowing that Kussmaul’s sign appears in only about a fifth of constrictive pericarditis cases, so its absence rules nothing out.

Causes of pericardial effusion

Pericardial effusions arise from pericarditis (inflammation causing fluid leak), obstruction of lymphatic drainage, or direct bleeding into the sac. Common causes by category:

Indications for pericardiocentesis

Emergency (tamponade): Hemodynamic instability with Beck’s triad, pulsus paradoxus >20 mmHg, or declining consciousness. This is a life-saving procedure – it cannot wait for elective scheduling.

Elective / diagnostic: Symptomatic large effusion without immediate hemodynamic compromise (dyspnea, chest pain, orthopnea). Fluid is sent for cytology, culture, cell count, and chemistry to identify the underlying cause.

Contraindications

The procedure: nurse’s role

Nurses do not perform pericardiocentesis, but pre-procedure preparation and intra-procedure monitoring are nursing responsibilities.

Pre-procedure preparation

• Confirm written informed consent is obtained
• Establish two large-bore IV lines
• Attach continuous cardiac monitoring (5-lead preferred) – baseline 12-lead ECG documented
• Position patient at 30–45° semi-recumbent (Fowler’s position): gravity shifts fluid anteriorly and inferiorly, pooling it near the subxiphoid needle entry point
• Baseline vital signs: HR, BP (both arms if aortic dissection possible), SpO2, RR
• Labs: CBC, coagulation studies (PT/INR, aPTT, platelets), type and screen
• Crash cart at bedside – defibrillator ready, ACLS drugs drawn
• Ultrasound machine prepared (echo guidance is now standard of care)
• Pericardiocentesis tray: needle (the 2025 ESC guidelines specify 16–20 gauge; an 18-gauge spinal needle is typical), 10–20 mL syringe, three-way stopcock, guidewire, dilator, pigtail catheter (if indwelling drain planned), specimen tubes (EDTA for cell count, red-top for chemistry/cytology, culture bottles)

During the procedure

The physician usually uses the subxiphoid approach: the needle is inserted between the left costal margin and the xiphoid process at a 45° angle, directed toward the left shoulder (left scapular tip). Ultrasound guidance confirms effusion depth and guides needle trajectory in real time. The 2025 ESC guidelines note that an apical or left-lateral approach may be used instead, and that CT or fluoroscopy can substitute for echocardiography as the guiding modality, so the tray and positioning may differ from the classic subxiphoid setup depending on where the fluid has collected.

Drainage volume carries a hard safety ceiling. Wherever possible the operator drains less than 500 mL at a single sitting, because emptying a large chronic effusion too quickly can precipitate pericardial decompression syndrome – acute pulmonary edema and ventricular dysfunction as the suddenly unloaded ventricles face a surge in filling. Complete drainage is achieved instead by leaving the catheter in place, typically for a few days, and removing it once daily output falls below 30 mL. A nurse who sees a rapidly filling collection bag well past 500 mL should raise it with the operator rather than simply recording the volume.

Nursing monitoring during procedure:

• Continuous ECG – if the needle touches the myocardium, the monitor shows ST elevation or premature ventricular beats (injury current). The nurse must immediately notify the physician so the needle can be withdrawn slightly.
• Blood vs effusion: pericardial blood (hemopericardium from chronic inflammation or trauma) does not clot, because it has been defibrinated by the motion of the beating heart. Ventricular blood clots rapidly. This differentiates accidental ventricular puncture from true hemopericardium aspiration.
• Vitals: BP and HR every 2–3 minutes – relief of tamponade shows as rapid BP improvement and HR decrease.
• Document volume aspirated and fluid characteristics (bloody, straw-colored, turbid).

Post-procedure monitoring

See cardiac monitoring and telemetry nursing for continuous ECG monitoring principles and rapid response and code blue nursing for ACLS protocol.

Pericardial fluid specimen analysis

A caution the older literature gets wrong: the 2025 ESC guidelines state that the classical Light criteria should not be applied to pericardial fluid. Those thresholds were derived for pleural effusions, and pericardial fluid is naturally rich in mesothelial cells, protein, albumin, and LDH – so applying them misclassifies a high proportion of pericardial samples as exudates. Protein and LDH are still sent and still reported, and cell count, cytology, culture, glucose, and ADA remain the values that drive the diagnosis. A student who has memorized the exudate/transudate cutoffs from a pleural effusion lecture should know they do not carry across.

Complications

Echocardiographic guidance changed the risk profile of this procedure, and older complication figures still circulating in study materials describe the blind technique. In the Mayo Clinic series of 1,127 consecutive echo-guided therapeutic pericardiocenteses over 21 years, the success rate was 97% and the total complication rate was 4.7% – 1.2% major and 3.5% minor. Blind pericardiocentesis, by contrast, carried morbidity approaching 20% and mortality as high as 6%. Any incidence figure in the low single-digit percentages for cardiac perforation should be read as a pre-ultrasound number.

For shock management principles, see shock nursing.

Patient education

Before the procedure:

• Explain what will happen: the physician will numb the skin near the breastbone, then insert a needle into the fluid around the heart
• The patient will feel pressure and possibly a brief sharp sensation; local anesthetic is used
• The patient must remain as still as possible during the procedure – any movement increases procedural risk
• The procedure typically takes 20–45 minutes

After the procedure:

• Report immediately: chest pain, shortness of breath, palpitations, dizziness, lightheadedness
• Activity restriction: no strenuous activity for 24 hours; bed rest if indwelling catheter is in place
• If an indwelling drain is left in, explain why: to allow complete drainage and prevent reaccumulation; it will be removed when daily output falls below about 30 mL
• Follow-up echocardiogram is typically scheduled within 1–2 weeks to confirm no fluid reaccumulation

NCLEX tips

1. Beck’s triad = hypotension + JVD + muffled heart sounds – all three together indicate cardiac tamponade
2. Pulsus paradoxus >10 mmHg = abnormal; >20 mmHg in a patient with pericardial disease = tamponade until proven otherwise
3. Electrical alternans on ECG – alternating QRS amplitude – is pathognomonic for large pericardial effusion and should raise immediate suspicion for tamponade
4. Position the patient at 30–45° (semi-Fowler’s) before pericardiocentesis – gravity pools fluid anteriorly near the needle entry site
5. Subxiphoid approach: needle aimed toward the LEFT shoulder – a frequently tested procedural detail
6. Pericardial blood does not clot – it has been defibrinated by cardiac motion; clotting after aspiration suggests ventricular puncture
7. ST elevation or PVCs during needle insertion = needle has touched the myocardium – notify the physician to withdraw slightly
8. JVD should DECREASE after successful pericardiocentesis – persistent or returning JVD signals incomplete drainage or reaccumulation
9. Aortic dissection is an absolute contraindication – pericardiocentesis can worsen hemopericardium; these patients need surgery
10. Most common cause of malignant pericardial effusion = lung cancer, followed by breast cancer and lymphoma
11. Uremic pericarditis produces an exudative effusion; hemodialysis is the primary treatment, not pericardiocentesis
12. Post-procedure priority: continuous cardiac monitoring, repeat 12-lead ECG, and CXR to rule out pneumothorax
13. Reaccumulation signs = return of Beck’s triad after initial improvement – this is an emergency requiring re-notification of the physician
14. Kussmaul’s sign = JVD increases on inspiration (paradoxical) – characteristic of constrictive pericarditis and absent in tamponade. That absence is what makes it useful: it is a discriminator between the two, so an exam item pairing Kussmaul’s sign with tamponade is testing the distinction
15. Nurse’s role = assessment, preparation, positioning, monitoring, specimen labeling, patient education – NOT needle insertion
16. Emergency pericardiocentesis cannot wait for lab results or optimal conditions when the patient is hemodynamically unstable – act, do not delay
17. Crash cart at bedside is mandatory during pericardiocentesis – ventricular arrhythmias and cardiac arrest are possible complications

Related clinical skills

Managing cardiac tamponade requires integrating multiple clinical skills:

• Pericarditis nursing – the most common cause of pericardial effusion leading to tamponade
• Cardiac monitoring and telemetry nursing – continuous ECG monitoring during and after the procedure
• 12-lead ECG interpretation – electrical alternans, ST changes, low-voltage QRS
• Arterial line nursing – continuous BP monitoring in hemodynamically unstable patients
• MI and ACS nursing – post-MI Dressler syndrome as a cause of pericardial effusion
• Rapid response and code blue nursing – ACLS for procedural complications
• ABG interpretation – metabolic acidosis in cardiogenic shock
• Shock nursing – obstructive shock physiology in cardiac tamponade

References

1. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46(40):3952–4041. doi:10.1093/eurheartj/ehaf192
2. Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921–2964. doi:10.1093/eurheartj/ehv318
3. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–1197. doi:10.1093/eurheartj/ehs372
4. Tsang TS, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77(5):429–436. doi:10.4065/77.5.429
5. Tsang TS, Freeman WK, Sinak LJ, Seward JB. Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc. 1998;73(7):647–652. doi:10.4065/73.7.647
6. Maggiolini S, Bozzano A, Russo P, et al. Echocardiography-guided pericardiocentesis with probe-mounted needle: report of 53 cases. J Am Soc Echocardiogr. 2001;14(8):821–824. doi:10.1067/mje.2001.114009
7. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349(7):684–690. doi:10.1056/NEJMra022643
8. Ristić AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35(34):2279–2284. doi:10.1093/eurheartj/ehu217
9. Curtiss EI, Reddy PS, Uretsky BF, Cecchetti AA. Pulsus paradoxus: definition and relation to the severity of cardiac tamponade. Am Heart J. 1988;115(2):391–398. doi:10.1016/0002-8703(88)90487-5
10. Reddy PS, Curtiss EI, O’Toole JD, Shaver JA. Cardiac tamponade: hemodynamic observations in man. Circulation. 1978;58(2):265–272. doi:10.1161/01.cir.58.2.265
11. Goldberger AL, Shabetai R, Bhargava V, West BJ. Nonlinear dynamics, electrical alternans, and pericardial tamponade. Am Heart J. 1984;107(6):1297–1299. doi:10.1016/0002-8703(84)90301-6
12. Sotolongo RP, Horton JD. Total electrical alternans in pericardial tamponade. Am Heart J. 1981;101(6):853–855. doi:10.1016/0002-8703(81)90627-x
13. Price S, Prout J, Jaggar SI, Gibson DG, Pepper JR. ‘Tamponade’ following cardiac surgery: terminology and echocardiography may both mislead. Eur J Cardiothorac Surg. 2004;26(6):1156–1160. doi:10.1016/j.ejcts.2004.08.020
14. Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med. 1993;95(2):209–213. doi:10.1016/0002-9343(93)90262-n
15. Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases: executive summary. Eur Heart J. 2004;25(7):587–610. doi:10.1016/j.ehj.2004.02.002
16. Hoit BD. Pericardial disease and pericardial tamponade. Crit Care Med. 2007;35(8 Suppl):S355–S364. doi:10.1097/01.CCM.0000271159.84639.2B
17. Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis (IMPI). N Engl J Med. 2014;371(12):1121–1130. doi:10.1056/NEJMoa1407380